These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15814108)

  • 21. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease.
    Lee ST; Park JE; Kim DH; Kim S; Im WS; Kang L; Jung SH; Kim MW; Chu K; Kim M
    Brain Res; 2008 Feb; 1194():130-7. PubMed ID: 18166168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of brain-derived neurotrophic factor against neurotoxicity of 3-nitropropionic acid in rat cortical neurons.
    Wu CL; Hwang CS; Yang DI
    Neurotoxicology; 2009 Jul; 30(4):718-26. PubMed ID: 19428112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype.
    Tadros MG; Khalifa AE; Abdel-Naim AB; Arafa HM
    Pharmacol Biochem Behav; 2005 Nov; 82(3):574-82. PubMed ID: 16337998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF.
    Puerta E; Hervias I; Barros-Miñones L; Jordan J; Ricobaraza A; Cuadrado-Tejedor M; García-Osta A; Aguirre N
    Neurobiol Dis; 2010 May; 38(2):237-45. PubMed ID: 20109548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism.
    Brouillet E; Hyman BT; Jenkins BG; Henshaw DR; Schulz JB; Sodhi P; Rosen BR; Beal MF
    Exp Neurol; 1994 Oct; 129(2):175-82. PubMed ID: 7525331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial impairment induced by 3-nitropropionic acid is enhanced by endogenous metalloprotease activity inhibition in cultured rat striatal neurons.
    de Oca Balderas PM; Ospina GG; Del Ángel AS
    Neurosci Lett; 2013 Jun; 546():16-20. PubMed ID: 23643981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paradoxical increase in 3-nitropropionic acid neurotoxicity by alpha-phenyl-tert-butyl-nitrone, a spin-trapping agent.
    Lan MY; Chang YY; Chen SS; Wu HS; Chen WH; Liu JS
    Chang Gung Med J; 2005 Feb; 28(2):77-84. PubMed ID: 15880982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.
    Kumar P; Kumar A
    Behav Brain Res; 2010 Jan; 206(1):38-46. PubMed ID: 19716383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of ginseng components in a rodent model of neurodegeneration.
    Lian XY; Zhang Z; Stringer JL
    Ann Neurol; 2005 May; 57(5):642-8. PubMed ID: 15852378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions.
    Maragos WF; Jakel RJ; Pang Z; Geddes JW
    Exp Neurol; 1998 Dec; 154(2):637-44. PubMed ID: 9878198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6 protects cultured cerebellar granule neurons against glutamate-induced neurotoxicity.
    Peng YP; Qiu YH; Lu JH; Wang JJ
    Neurosci Lett; 2005 Feb; 374(3):192-6. PubMed ID: 15663961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.
    Beal MF; Brouillet E; Jenkins BG; Ferrante RJ; Kowall NW; Miller JM; Storey E; Srivastava R; Rosen BR; Hyman BT
    J Neurosci; 1993 Oct; 13(10):4181-92. PubMed ID: 7692009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction.
    Costa C; Tozzi A; Luchetti E; Siliquini S; Belcastro V; Tantucci M; Picconi B; Ientile R; Calabresi P; Pisani F
    Exp Neurol; 2010 Jan; 221(1):217-24. PubMed ID: 19913015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease.
    Park JE; Lee ST; Im WS; Chu K; Kim M
    Neurosci Lett; 2008 Dec; 448(1):143-7. PubMed ID: 18938211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time-course correlation of early toxic events in three models of striatal damage: modulation by proteases inhibition.
    Pérez-De La Cruz V; Elinos-Calderón D; Carrillo-Mora P; Silva-Adaya D; Konigsberg M; Morán J; Ali SF; Chánez-Cárdenas ME; Pérez-De La Cruz G; Santamaría A
    Neurochem Int; 2010; 56(6-7):834-42. PubMed ID: 20332007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective role of sertraline against 3-nitropropionic acid-induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain.
    Kumar P; Kumar A
    Indian J Exp Biol; 2009 Sep; 47(9):715-22. PubMed ID: 19957883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Energy and glutamate dependency of 3-Nitropropionic acid neurotoxicity in culture.
    Fink SL; Ho DY; Sapolsky RM
    Exp Neurol; 1996 Apr; 138(2):298-304. PubMed ID: 8620928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease.
    Keene CD; Rodrigues CM; Eich T; Linehan-Stieers C; Abt A; Kren BT; Steer CJ; Low WC
    Exp Neurol; 2001 Oct; 171(2):351-60. PubMed ID: 11573988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic administration of malonic acid produces selective neural degeneration and transient changes in calbindin immunoreactivity in rat striatum.
    Bazzett TJ; Falik RC; Becker JB; Albin RL
    Exp Neurol; 1995 Aug; 134(2):244-52. PubMed ID: 7556544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective effects mediated by dopamine receptor agonists against malonate-induced lesion in the rat striatum.
    Fancellu R; Armentero MT; Nappi G; Blandini F
    Neurol Sci; 2003 Oct; 24(3):180-1. PubMed ID: 14598076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.